World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
10656
World Ranking
3734
National Ranking
1716

Howard M. Gebel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Howard M. Gebel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 309 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Howard M. Gebel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Howard M. Gebel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Howard M. Gebel is affiliated with Emory University in the United States. Their research primarily spans the field of Medicine with a distinct focus on surgery, transplantation, immunology, infectious diseases, and hematology.

Their significant work covers several topics including:

  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • SARS-CoV-2 and COVID-19 Research
  • Transplantation: Methods and Outcomes
  • T-cell and B-cell Immunology
  • Renal Diseases and Glomerulopathies
  • Blood groups and transfusion

Howard M. Gebel has authored multiple papers with notable recent publications including:

  • "Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report," 2020, American Journal of Transplantation
  • "Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document," 2023, American Journal of Transplantation
  • "Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report," 2023, American Journal of Transplantation
  • "Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins," 2020, Transplantation
  • "On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss," 2021, Kidney International Reports

The researcher frequently collaborates with other scientists, notably with Robert A. Bray, Harold C. Sullivan, Anna B. Morris, Jonathan S. Maltzman, and E. Steve Woodle.

The journals where Howard M. Gebel's research is most often published include:

  • Human Immunology
  • American Journal of Transplantation
  • Transplantation
  • Kidney International Reports
  • Transplant Immunology

Best Publications

  • Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

    Brian D. Tait;Caner Süsal;Howard M. Gebel;Peter W. Nickerson

  • Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.

    Howard M. Gebel;Robert A. Bray;Peter Nickerson

  • Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis

    Nasir Rana;Donald P. Braun;Robert House;Howard Gebel

  • Transplanting the highly sensitized patient : The emory algorithm

    R. A. Bray;J. D. L. Nolen;C. Larsen;T. Pearson

  • Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

    Anat R. Tambur;Patricia Campbell;Frans H. Claas;Sandy Feng

  • Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics

    Carlos A. Vieira;Avinash Agarwal;Benita K. Book;Richard A. Sidner

  • Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody

    Denise L. Faustman;Ralph M. Steinman;Howard M. Gebel;Vera Hauptfeld

  • Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.

    Elaine F. Reed;Ping Rao;Zilu Zhang;Howard Gebel

  • Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation

    T. B. Dunn;H. Noreen;K. Gillingham;D. Maurer

  • Sensitization and sensitivity: defining the unsensitized patient.

    Howard M. Gebel;Robert A. Bray

  • Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.

    Anat R. Tambur;Patricia Campbell;Anita S. Chong;Sandy Feng

  • HLA Antibody Detection With Solid Phase Assays: Great Expectations or Expectations Too Great?

    H. M. Gebel;R. A. Bray

  • APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

    Barry I. Freedman;Stephen O. Pastan;Ajay K. Israni;David Schladt

  • Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

    Barry I. Freedman;Bruce A. Julian;Stephen O. Pastan;Ajay K. Israni

  • Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test.

    Thomas C. Fuller;Donna Phelan;Howard M. Gebel;Glenn E. Rodey

  • The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.

    Robert A. Bray;Lauralynn K. Lebeck;Howard M. Gebel

  • Evolution of HLA antibody detection: technology emulating biology.

    Robert A. Bray;Peter W. Nickerson;Ronald H. Kerman;Howard M. Gebel

  • De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.

    Robert A Bray;Howard Gebel;R. Townsend;M. E. Roberts

  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.

    Wasim A Dar;A. Agarwal;C. Watkins;H. M. Gebel

  • Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors

    Allan D. Kirk;Antonio Guasch;He Xu;Jennifer Cheeseman

  • Multidrug resistance activity in human lymphocytes.

    John S. Coon;Yazhang Wang;Steven D. Bines;Penelope N. Markham

  • Translational Applications of Flow Cytometry in Clinical Practice

    David L. Jaye;Robert A. Bray;Howard M. Gebel;Wayne A. C. Harris

Frequent Co-Authors

Peter Nickerson
Peter Nickerson University of Manitoba
Christian P. Larsen
Christian P. Larsen Emory University
Anita S. Chong
Anita S. Chong University of Chicago
Malek Kamoun
Malek Kamoun University of Pennsylvania
Allan D. Kirk
Allan D. Kirk Duke University
Thomas C. Pearson
Thomas C. Pearson Emory University
Elaine F. Reed
Elaine F. Reed University of California, Los Angeles
Frans H.J. Claas
Frans H.J. Claas Leiden University Medical Center
Adriana Zeevi
Adriana Zeevi University of Pittsburgh
E. Steve Woodle
E. Steve Woodle University of Cincinnati Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students start with foundational nursing programs. Finding easy admission LPN programs offers a practical entry point for aspiring nurses, providing hands-on experience in patient care.

Advancing to roles like nurse practitioner is a natural progression. Identifying nurse practitioner programs with easy admission can help students navigate the competitive application process.

Specializing further, programs such as psychiatric mental health nurse practitioner (PMHNP) degrees integrate Immunology principles with mental health care. Prospective students should consider the best online pmhnp programs to ensure strong clinical training and successful career placement.

Cost is also a major concern. Those seeking affordable options will benefit from exploring the cheapest pmhnp certificate programs, which balance quality education with cost-effectiveness.

Best Scientists Citing Howard M. Gebel

Trending Scientists

Recently Published Articles